Life Insurance with a Thyroid Condition in Canada: What Carriers Actually Check
By Parvesh Benning, Licensed Life Insurance Broker
The diagnosis itself doesn’t drive the outcome. Four things do.
A stable thyroid condition is what I’d consider a non-event for life insurance. Most carriers won’t even flag it if your medication has been steady for six months or longer. But the gap between a routine approval and a postponement comes down to details most applicants overlook: when your dosage last changed, whether any investigations are still open, and which carrier sees your specific situation most favourably.
Updated: April 22, 2026
Life Insurance with a Thyroid Condition in Canada: What Carriers Actually Check
By Parvesh Benning, Licensed Life Insurance Broker
The diagnosis itself doesn’t drive the outcome. Four things do.
A stable thyroid condition is what I’d consider a non-event for life insurance. Most carriers won’t even flag it if your medication has been steady for six months or longer. But the gap between a routine approval and a postponement comes down to details most applicants overlook: when your dosage last changed, whether any investigations are still open, and which carrier sees your specific situation most favourably.
Updated: April 22, 2026
A stable thyroid condition is what I’d consider a non-event for life insurance. Most carriers won’t even flag it if your medication has been steady for six months or longer. But the gap between a routine approval and a postponement comes down to details most applicants overlook: when your dosage last changed, whether any investigations are still open, and which carrier sees your specific situation most favourably.
This guide breaks down how thyroid conditions are actually assessed by Canadian insurers, what underwriters check beyond the diagnosis, and how a broker routes these cases to get the best outcome.
Can you get life insurance with a thyroid condition in Canada?
Most Canadians with hypothyroidism, hyperthyroidism, or Graves’ disease qualify for standard life insurance rates once their condition is stable and medication hasn’t changed in the past 6 to 12 months. The diagnosis alone is not what drives the underwriting outcome. Carriers focus on four factors: stability, medication changes, recency of treatment, and whether any investigations are still open.
What to expect by condition:
- Stable hypothyroid on levothyroxine: Standard rates at most carriers. Often treated as a non-event.
- Hyperthyroidism or Graves’ disease (treated, stable): Standard to +200% depending on carrier and time since treatment.
- Thyroid nodule under investigation: Postponed across all carriers until workup is complete.
- Thyroid cancer survivor (3+ years post-treatment): Coverage available through both fully underwritten and simplified paths.
Guide contents
Can You Get Life Insurance with a Thyroid Condition?
Someone with a stable thyroid condition should have no issues getting a fully underwritten standard policy in Canada. That covers the majority of people reading this. If you’ve been on the same medication for six months or more, your levels are steady, and there are no open investigations, you’re looking at a straightforward application at most carriers.
What changes the picture is the type of thyroid condition and whether anything is still being sorted out medically. A controlled hypothyroid case and an active Graves’ disease case with recent radioactive iodine treatment are completely different files from an underwriter’s perspective, even though both involve the thyroid.
Hypothyroidism (Including Hashimoto’s)
Most applications don’t even ask specifically about thyroid. Simplified issue forms tend to focus on broader questions: are there any ongoing investigations, abnormal test results, or medication changes in the past year? If none of those apply, hypothyroidism on levothyroxine barely registers.
On the fully underwritten side, Canada Life’s position is that treated hypothyroidism has no significance to insurability. Sun Life and Empire Life both offer standard rates when the condition is asymptomatic and treated. Foresters follows the same pattern as long as there are no cardiac or other associated conditions. If you have Hashimoto’s disease specifically, the autoimmune label does not change the outcome when thyroid levels are controlled.
Hyperthyroidism and Graves’ Disease
Graves’ disease gets more scrutiny because the carrier outcome range is wider. Was medication changed in the last 6 to 12 months? Are there any ongoing monitoring flags? Those are the things I’m watching for before deciding where to submit.
Empire Life requires a report from your doctor and will decline applications within six months of treatment. After six months, outcomes range from standard rates to a 200% rating depending on the full picture. If there’s persistent eye involvement, critical illness coverage may come with a blindness exclusion. Sun Life postpones anyone who is untreated or still symptomatic, but once treatment is stable and symptoms have resolved, standard rates are realistic. Foresters is similar on straightforward cases, but if cardiac complications develop, the file escalates to higher ratings or a decline.
This is where a preliminary assessment becomes useful. The spread between carriers on Graves’ is wide enough that submitting to the wrong one first can mean an unnecessary decline sitting on your record.
Thyroid Nodules Under Investigation
Any ongoing investigation will result in your application being deferred.
If your doctor is monitoring a thyroid nodule and no biopsy has been completed, every carrier will postpone. Simplified or fully underwritten, it does not matter. Complete the investigation first, get the results, then apply. This is the single most common timing mistake on thyroid cases.
Once a nodule has been classified, Sun Life uses the TI-RADS scoring system to determine the outcome. A TI-RADS 1 or 2 means standard rates for both life and critical illness coverage. TI-RADS 3 may still result in a postponement if the classification is less than a year old, but standard rates are possible after compliant follow-up. Anything scored TI-RADS 4 or higher is a postponement until further workup.
What Underwriters Actually Check on Thyroid Applications
The diagnosis itself doesn’t drive the outcome on a thyroid application. Most people think it’s just the thyroid, it’s controlled, and they’re fine. Usually that’s correct. But underwriters look past the label on the file. They evaluate four specific factors, and these are what actually determine whether you get standard rates, a rating, or a postponement.
Stability
How long your thyroid levels have been in normal range. Twelve months of consistent TSH and T4 is the standard most carriers look for before offering standard rates. For straightforward hypothyroidism on levothyroxine, six months is often enough.
Medication Changes
Whether your dosage has been adjusted in the past 6 to 12 months. A recent change signals the condition may not be fully controlled yet. Carriers treat a dosage adjustment differently from a full medication switch: adjustments are minor flags, switches are bigger ones.
Recency
How recently was anything diagnosed, treated, or changed? A diagnosis from five years ago with no issues since is a clean file. Radioactive iodine treatment or thyroid surgery within the past six months means most carriers will postpone until levels stabilize on replacement therapy.
Open Investigations
This is the factor that catches people off guard. Even a routine monitoring ultrasound that hasn’t been completed can trigger a postponement. Any pending biopsy, incomplete bloodwork, or unresolved imaging result means the file cannot move forward. Every investigation must be closed before applying. No exceptions, regardless of carrier.
These four factors don’t exist in isolation. Someone with stable hypothyroidism and nothing else going on is a routine file. But combine hyperthyroidism with a recent medication change, or Graves’ disease with cardiac complications, and the underwriting picture shifts. Carriers like Sun Life, Empire Life, Canada Life, and Foresters each weigh these factors differently, which is why where the application goes first often matters as much as what’s on it.
How Thyroid Cases Are Routed Across Carriers
A broker routes thyroid cases using internal carrier guides before anything gets submitted formally. I already have that data and lots of experience that let me understand, based on those guides, where a client will land. That’s the step most people skip when they go direct or apply through their bank. They pick one carrier, hope for the best, and if the answer comes back no, there’s a decline sitting on their record making the next application harder.
The same thyroid condition at the same stage of control produces completely different outcomes depending on where you apply. These two routing scenarios show why.
Routing: Stable Hypothyroid on Medication
Canada Life: Standard. Their position is treated hypothyroidism has no significance to insurability.
Sun Life: Standard if treated and asymptomatic.
Empire Life: Standard if no symptoms, treated or untreated.
Foresters: Standard if no cardiac or associated conditions.
Desjardins: Standard if treated and properly managed.
Routing: Graves’ Disease / Active Hyperthyroid
Sun Life: Postpone if symptomatic. Standard once treated and stable on medication.
Empire Life: Decline within 6 months of treatment. After 6 months: standard to +200%. APS required. Persistent exophthalmos may trigger CI blindness exclusion.
Foresters: Standard if straightforward. Cardiac complications escalate to substandard or decline.
Ivari: Standard if controlled. Rating to decline based on severity.
That spread on Graves’ is exactly why I don’t guess where to submit. I run a preliminary assessment first. It’s an email to the underwriting department or an internal contact at the carriers I’m considering. Always generic information, never includes the client’s name. I lay out the medical specs and ask where this person would land. They come back with an indication. The whole thing takes about 30 minutes, and it prevents the one thing that actually damages a file: an avoidable decline on record.
Very rarely do I end up with a thyroid client who is outright declined. Either the internal guides give me a clear answer upfront, or the preliminary assessment confirms the landing spot before we move forward. The cases that get complicated are the ones where Graves’ overlaps with other health factors, or where recent radioactive iodine treatment means every fully underwritten carrier will postpone.
In those situations, I compare the fully underwritten path against no-medical providers that offer immediate coverage without the medical deep-dive. I’ve had Graves’ cases where the rating was so high it pushed the client into a very expensive policy, and a simplified provider was actually more cost-effective for the same face amount. Not all policies are created equal. Even between simplified and guaranteed issue providers, the health questions vary: some ask about thyroid treatment within the last 2 years, others 3, others 5. Knowing those form-level differences is how you find coverage today.
What to Do if You Were Rated or Postponed
A postponed decision at one carrier does not mean you’re postponed everywhere. Thyroid cases have more options after a setback than most people realize, and the next step depends entirely on which outcome you received.
If you were rated (approved at a higher premium)
Don’t accept the offer without comparing. I’ve had thyroid cases where the fully underwritten rating pushed the premium so high that a simplified provider was more cost-effective for the same coverage amount. Always run that comparison before signing.
If you’d rather keep the underwritten policy, that number isn’t permanent. Twelve months of stable labs with no medication changes is usually enough to request a reconsideration from the same carrier. The broker goes back with updated records and asks for a review. If the condition has improved, the rate comes down.
If you were postponed (told to wait and reapply)
This usually means the carrier needs more stability data. Recent radioactive iodine, a thyroidectomy still healing, or lab values that haven’t settled. The timeline is typically 6 to 12 months before they’ll look at the file again.
You do not have to wait uncovered. Even between simplified providers, the health questions vary. Some ask about thyroid treatment within the last 2 years, others 3, others 5. That variation in question windows is how a broker finds coverage today while the fully underwritten path reopens later.
If you were declined outright
Rare on thyroid cases, but it happens when Graves’ disease overlaps with serious cardiac complications or when recent treatment is too fresh. A decline at one carrier does not close every door. Simplified and guaranteed issue products don’t use the same underwriting, and a decline on a fully underwritten application has zero impact on those paths.
Critical illness coverage is also worth exploring separately. Some carriers will issue CI with a thyroid exclusion rather than declining the entire application. That means the rest of your coverage stays intact even if the thyroid condition is carved out.
Thyroid Cancer and Life Insurance
Three years is a great window for thyroid cancer survivors because it opens up a lot more options. That’s the threshold where simplified providers start asking different questions, and fully underwritten carriers become willing to look at the file seriously.
The approach I take on a thyroid cancer case depends on timing. If treatment ended more than three years ago and follow-ups are clean, I still submit to a fully underwritten carrier first. There will likely be a rating involved, but I want to see what that number is. Then I compare it against simplified providers that allow immediate coverage with no delay. At that point it becomes a straight premium comparison for the same face amount. Sometimes the fully underwritten option wins. Sometimes it doesn’t.
What carriers typically look at on thyroid cancer files:
- Cancer type: Papillary (most common, most favourable) is treated very differently from medullary or anaplastic
- Staging and tumour size: Sun Life uses detailed staging tables. Empire Life factors tumour size, with cases under 2cm qualifying sooner
- Time since treatment: Beneva can offer standard rates as early as 6 months post-treatment for Stage I papillary under age 55. Most other carriers require 2 to 3 years minimum
- Follow-up results: Clean scans, stable thyroid replacement therapy, and low thyroglobulin levels strengthen the application at every carrier
There is definitely a path to get immediate coverage today, even while the fully underwritten timeline is still running. That’s the part most people miss. They assume it’s one or the other. It’s not. You can hold a simplified policy now and convert to a fully underwritten policy once the timing works.
Thyroid cancer underwriting gets detailed quickly, especially once staging, carrier-specific flat extras, and CI exclusion rules come into play. For the full breakdown of how each carrier handles papillary, follicular, medullary, and anaplastic cases, see our dedicated guide on life insurance with thyroid cancer in Canada.
Frequently Asked Questions
1. Can you get life insurance with a thyroid condition in Canada?
Yes, and in most cases it’s straightforward. A stable hypothyroid condition on medication is treated as a non-event by the majority of carriers. Hyperthyroidism and Graves’ disease require more carrier-specific routing, but standard rates are realistic once treatment is stable and symptoms have resolved. The key factor is not the diagnosis itself but whether your medication, lab results, and follow-up history show consistent control.
2. Does thyroid medication affect your life insurance application?
Levothyroxine and similar thyroid replacement medications are among the most commonly prescribed drugs in Canada. Taking them is not a negative signal to underwriters. What matters is whether the dosage has been stable. If your medication changed in the past 6 to 12 months, some carriers may wait for updated labs before issuing a decision. If the dose has been steady, most applications move through without issue. Many simplified issue applications don’t even ask specifically about thyroid medication.
3. What happens if your thyroid condition was just diagnosed?
A brand-new diagnosis typically means a short postponement on fully underwritten applications while your treatment stabilizes. The same applies if you have any open investigations: a pending biopsy, incomplete bloodwork, or a monitoring ultrasound that hasn’t been read. Every carrier will defer the application until those results are closed. The best move is to complete all testing, get stable on your medication, and then apply once your doctor confirms your levels are in range.
4. Can thyroid cancer survivors get life insurance?
Yes. Three years post-treatment is a meaningful threshold because it opens up both fully underwritten options (likely with a rating) and simplified providers that offer immediate coverage. The routing depends on cancer type, staging, and follow-up results. Papillary thyroid cancer at early stages qualifies sooner than medullary or anaplastic. For a full breakdown of carrier-specific staging rules, see our guide on life insurance with thyroid cancer in Canada.
5. What is the difference between fully underwritten and simplified issue for thyroid applicants?
Fully underwritten policies involve a health questionnaire, possibly a medical exam, and a review of your doctor’s records. They offer the lowest premiums and highest coverage amounts when your thyroid condition is well controlled. Simplified issue policies skip the medical exam and use a short set of health questions instead. Premiums are higher, but approval is faster and the health questions may not even mention thyroid specifically. Accelerated underwriting sits between the two: a fully underwritten policy that waives the exam when your health profile qualifies. A broker typically tries the fully underwritten path first because of cost, then compares against simplified options if the rating comes back too high.
6. Will your premiums go down if your thyroid condition improves?
They can. If you were rated at the time of approval, twelve months of stable lab results with no medication changes is usually enough to request a reconsideration from the same carrier. You don’t need to start a new application. The broker who placed the original policy goes back with updated records and asks for a rate review. This is standard practice on thyroid cases and one of the reasons it’s worth working with a broker who tracks your file over time.
Not sure where your thyroid condition puts you with carriers?
A preliminary assessment takes about 30 minutes and tells you exactly where you’d land before anything goes on your record. Whether you’re stable on medication, recently treated, or dealing with a postponement from another provider, the routing starts with understanding what each carrier actually needs to see.
Get in touch here or call 1-877-654-6119
Proudly based in Hamilton. Serving clients across Ontario, British Columbia, Alberta, Manitoba, Saskatchewan, Nova Scotia, and New Brunswick, including Vaughan, Medicine Hat, and Kelowna.
